We examined the effect of chronic CCL3 treatment on the properties of cultured rat hippocampal neurons to gain an understanding of the neuronal effects of CCL3 during neuroinflammatory disorders. Western blot assays showed that chronic exposure to CCL3 altered the level of specific neuronal and glial proteins and that CCL3 had no effect on neuronal survival. CCL3 treatment also altered intracellular Ca 2+ dynamics and increased Ca 2+ levels in hippocampal neurons, measured by fura-2 imaging techniques. Additionally, chronic CCL3 increased NMDA-evoked Ca 2+ signals in the hippocampal neurons and increased NMDA receptor levels. These CCL3-induced neuroadaptive changes could play an important role in the CNS dysfunction associated with CNS disorders with a neuroinflammatory component.
Introduction
Emerging research indicates that chemokines are important signaling molecules in the central nervous system (CNS) (Adler et al., 2005; Miller et al., 2008) . Chemokines belong to a family of small proteins initially identified for their role in the immune system as inflammatory and chemoattractive factors (Wells et al., 1998) . Microglia and astrocytes are prominent sources of chemokines within the CNS, but some neurons also produce chemokines (Biber et al., 2006) . The biological effects of chemokines are produced through the activities of cognate G-protein coupled receptors and several downstream signal transduction pathways including inhibition of adenylate cyclase, activation of MAP kinase and activation of phospholipase C (PLC) (Bajetto et al., 2002; Maghazachi, 2000) . To date, approximately 50 chemokines and 20 chemokine receptors have been identified, many of which are expressed in the CNS (Adler and Rogers, 2005) .
Chemokine levels in the CNS are generally low under normal conditions, but increased expression is induced by adverse conditions such as brain injury or disease and provides an important signal for the inflammatory cell recruitment to the CNS in the host defense response (Tran and Miller, 2003) . For example, the chemokine CCL3 (chemokine 3; also known as MIP-1 or macrophage inflammatory protein-1) a 7.8 kDa protein and other components of the innate immune system are highly up regulated in the hippocampus of temporal lobe epilepsy (TLE) patients (Lee et al., 2007; van Gassen et al., 2008) . Increased levels of CCL3 also occur during epileptogenesis in animal models of temporal lobe epilepsy, suggesting a role for CCL3 in this condition (Gorter et al., 2006; Lukasiuk et al., 2006) . Studies also implicate a role for CCL3 in experimental autoimmune encephalomyelitis (EAE), a demyelinating disease model of the CNS that is a model for multiple sclerosis (Glabinski et al., 1998) . During the course of EAE, the CNS levels of CCL3 mRNA and protein are up regulated and correlate with the severity of the clinical episode (Karpus et al., 1995) . Other conditions associated with the increased levels of CCL3 in the CNS include closed head injury (Israelsson et al., 2009) Neuronal expression of mRNA and protein for CCR3, a cognate receptor for CCL3, has been demonstrated in several CNS regions, consistent with the ability of neurons to respond to CCL3. For example, studies show that CCR3 immunopositive neurons are present in the hippocampus, cerebral cortex, brain stem, cerebellum and spinal cord (Ishizuka et al., 1997; van der Meer et al., 2000; Xia et al., 1998; Xu et al., 2009) . These results raise the possibility that the functional properties of CNS neurons could be altered by CCL3 when elevated levels of CCL3 are present in the CNS, as occurs during CNS neuroinflammation. Few studies have investigated this possibility, which could have important implications relative to the effects of neuroinflammation on cognitive function. To provide information on this issue, we have investigated the effects of CCL3 on hippocampal neurons using a culture model system. 
